elimusertib
bayer
['elimusertib']
#cedarssinaicancer at #aacr23. dr. timothy diperi is co-author on the poster #antitumor activity of the atr inhibitor elimusertib in patient-derived #xenograft models with dna damage response pathway alterations presented at 6:00am pt. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.